Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 1:51 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2761–2784 of 17,772 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Population Clear all

Conditions: Mental Health, Mental Health Help-Seeking, Mental Health Literacy
Interventions: Mental Health Youth Series; Other
Lead sponsor: Sanctuary Mental Health Ministries; Other
Eligibility: 11 Years to 18 Years
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Colorado Springs, Colorado

Conditions: Coping
Interventions: Formal Mindful Self-Compassion (MSC-F), Informal Mindful Self-Compassion (MSC-I); Behavioral
Lead sponsor: Cambridge Health Alliance; Other
Eligibility: 14 Years to 19 Years
Enrollment: 135 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Malden, Massachusetts

Conditions: End-stage Renal Disease, Prevention of Thromboembolic Events, Hemodialysis, Hemodiafiltration
Interventions: BAY1213790 (Osocimab), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 704 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 26
States / cities: Azusa, California • Brawley, California • Encino, California + 21 more

Conditions: Maternal Psychological Distress, Perinatal Depression, Self-Regulation, Emotion
Interventions: Trauma Informed Prenatal Intervention (TPI), Prenatal Education Topics; Behavioral · Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: High Risk Cancer, Lung Cancer
Interventions: Median LCS; Device
Lead sponsor: Median Technologies; Industry
Eligibility: 50 Years to 80 Years
Enrollment: 480 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 3
States / cities: Philadelphia, Pennsylvania • Memphis, Tennessee • Houston, Texas

Conditions: Hypertension
Interventions: Behavioral feedback; Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 60 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Dietary Habits, Physical Inactivity, Sleep Hygiene
Interventions: Experimental; Behavioral
Lead sponsor: Tufts University; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Pectus Excavatum, Pain, Postoperative
Interventions: Ultrasound-guided Sub-Paraspinal Block, PCA only; Procedure
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 12 Years to 17 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Postherpetic Neuralgia
Interventions: Civamide Nasal Spray, Placebo; Drug
Lead sponsor: Winston Laboratories; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 5
States / cities: Santa Monica, California • Lauderdale Lakes, Florida • Tampa, Florida + 2 more

Conditions: Substance Use Disorder
Interventions: MRI: Brain Imaging Data Collection; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 45 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Health Behavior, Well-Being
Interventions: Resilience-Supportive Leadership Training (RESULT); Behavioral
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years and older
Enrollment: 1,890 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Tacoma, Washington

Conditions: Alcohol Use Disorder
Interventions: Detoxification Program, PKAB, CFN; Other · Radiation
Lead sponsor: Yale University; Other
Eligibility: 21 Years to 70 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Stress, Psychological, Stress, Emotional, Stress, Physiological
Interventions: Ethnic and Racial Identity Promotion, Academic Skills Promotion; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 13 Years to 18 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2032
U.S. locations: 3
States / cities: Evanston, Illinois • Niles, Illinois

Conditions: Alzheimer's Disease
Interventions: KarXT, KarX-EC, Placebo; Drug · Other
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 60 Years to 85 Years
Enrollment: 586 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 31
States / cities: Fullerton, California • Irvine, California • Los Angeles, California + 28 more

Conditions: Pre Diabetes
Interventions: Exenatide SR; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Pregnancy Prevention, Life Skill Development
Interventions: Healthy Adolescent Transitions (HAT) program; Behavioral
Lead sponsor: Jack Stevens; Other
Eligibility: 14 Years to 19 Years · Female only
Enrollment: 331 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Mental Health, Resilience, Self-Compassion, Empowerment, Well-Being, Psychological, Burnout, Healthcare Workers
Interventions: RISE for Nurse Preceptors Program; Behavioral
Lead sponsor: AdventHealth; Other
Eligibility: 18 Years and older
Enrollment: 124 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Body Sculpting
Interventions: Non Invasive Ultrasound; Device
Lead sponsor: UltraShape; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 156 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 4
States / cities: Metairie, Louisiana • Hunt Valley, Maryland • Montclair, New Jersey + 1 more

Conditions: Sickle Cell Disease
Interventions: Aes-103, Placebo; Drug
Lead sponsor: Baxalta now part of Shire; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Mental Health Issues, Bipolar Disorder, Depressive, Schizophrenia Spectrum and Other Psychotic Disorders, Anxiety Disorder
Interventions: Group Music Therapy Advocacy Recording Intervention (MTAR); Behavioral
Lead sponsor: Hackensack Meridian Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Belle Mead, New Jersey

Conditions: Moderate-to-Severe Atopic Dermatitis
Interventions: Nemolizumab; Drug
Lead sponsor: Galderma R&D; Industry
Eligibility: 6 Months to 23 Months
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Chronic Spontaneous Urticaria
Interventions: Benralizumab, Placebo and Benralizumab; Biological
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years
Enrollment: 159 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 12
States / cities: Scottsdale, Arizona • Los Angeles, California • Mission Viejo, California + 8 more

Conditions: Anxiety
Interventions: Acceptance and Commitment Therapy; Behavioral
Lead sponsor: University of Iowa; Other
Eligibility: 25 Years to 65 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Hip Disease, Postoperative Pain
Interventions: Erector spinae block, Local block; Procedure
Lead sponsor: Carilion Clinic; Other
Eligibility: 13 Years to 50 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Roanoke, Virginia

Search by objective public record fields.

Sanctuary Youth Series Randomized Control Trial

The Effectiveness and Acceptability of Formal Versus Informal Mindful Self-Compassion for Adolescents

Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis

Reducing Stress-Sensitive Problems Among Pregnant Black Women With Childhood Adversity

Retrospective Clinical Trial Comparing Radiologists' Diagnosis Accuracy in Lung Cancer Screening Population With and Without the Help of an AI/ML Tech-based SaMD

Medication Adherence in Hypertension Study

HEART at Head Start Pilot (Healthy Eating, Activity, Relaxation Trial)

Sub-Paraspinal Block in Nuss Patients. A Pilot Project

Civamide Nasal Solution for Postherpetic Neuralgia of the Trigeminal Nerve

Functional Connectivity Changes During Early Recovery as a Marker for Relapse

Readiness Supportive Leadership Training

Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder

Biology, Identity & Opportunity Study

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation

Healthy Adolescent Transitions (HAT)

RISE for Nurse Preceptors

A Multicenter,2-Arm,Randomized,Controlled Study Evaluate the Effectiveness of the UltraShape® Contour I VER 3.1 System for Non-Invasive Reduction in Abdominal Circumference

A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell Disease

Music Therapy Advocacy Recording Intervention (MTAR) on Internalized Stigma

Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic Dermatitis

A Study to Investigate the Use of Benralizumab in Patients With Chronic Spontaneous Urticaria Who Are Symptomatic Despite the Use of Antihistamines (ARROYO)

Does Treating Anxiety Symptoms With ACT Improve Vascular Inflammation and Function?

Evaluating the Efficacy of Erector Spinae Block in Routine Hip Arthroscopy